Cargando…

Angiomotin Family Members: Oncogenes or Tumor Suppressors?

Angiomotin (Amot) family contains three members: Amot (p80 and p130 isoforms), Amot-like protein 1 (Amotl1), and Amot-like protein 2 (Amotl2). Amot proteins play an important role in tube formation and migration of endothelial cells and the regulation of tight junctions, polarity, and epithelial-mes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Meng, Shen, Yanwei, Yang, Jiao, Li, Shuting, Wang, Biyuan, Chen, Zheling, Li, Pan, Liu, Peijun, Yang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485632/ https://www.ncbi.nlm.nih.gov/pubmed/28656002 http://dx.doi.org/10.7150/ijbs.19603

Ejemplares similares

Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP
por: Lv, Meng, et al.
Publicado: (2016)

Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer
por: Yang, Jiao, et al.
Publicado: (2019)

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors
por: Lv, Meng, et al.
Publicado: (2017)

Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
por: Paramasivam, Murugan, et al.
Publicado: (2011)

Tumor location as a novel high risk parameter for stage II colorectal cancers
por: Wang, Biyuan, et al.
Publicado: (2017)

Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study
por: Yang, Jiao, et al.
Publicado: (2017)

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
por: Chen, Zheling, et al.
Publicado: (2017)

Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis
por: Li, Shuting, et al.
Publicado: (2017)

Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin
por: Shen, Yanwei, et al.
Publicado: (2019)

Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer
por: Shen, Yanwei, et al.
Publicado: (2017)

The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012
por: Yang, Jiao, et al.
Publicado: (2017)

Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
por: Jiang, Wen G, et al.
Publicado: (2006)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

Incidence and survival differences in esophageal cancer among ethnic groups in the United States
por: Chen, Zheling, et al.
Publicado: (2017)

Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
por: Li, Youjun, et al.
Publicado: (2015)

Angiomotin functions in HIV-1 assembly and budding
por: Mercenne, Gaelle, et al.
Publicado: (2015)

Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database
por: Li, Shuting, et al.
Publicado: (2019)

Hold That Line: Angiomotin Regulates Endothelial Cell Motility
por: Zetter, Bruce R.
Publicado: (2001)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Angiomotin-Like 1 Links Paramyxovirus M Proteins to NEDD4 Family Ubiquitin Ligases
por: Ray, Greeshma, et al.
Publicado: (2019)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

Angiomotins link F-actin architecture to Hippo pathway signaling
por: Mana-Capelli, Sebastian, et al.
Publicado: (2014)

Early prediction of revascularisation by angiomotin-targeting positron emission tomography
por: Moyon, Anais, et al.
Publicado: (2018)

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin
por: Moleirinho, Susana, et al.
Publicado: (2017)

Identification of Specific Lysines and Arginines That Mediate Angiomotin Membrane Association
por: Hall, Le’Celia, et al.
Publicado: (2019)

Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
por: Zeng, Hao, et al.
Publicado: (2016)

Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?
por: Wang, Yunmei, et al.
Publicado: (2019)

Clinicopathological features and survival of early stage breast cancer in northwest China: A population‐based retrospective study of 1287 patients
por: Li, Shuting, et al.
Publicado: (2017)

The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development
por: Hirate, Yoshikazu, et al.
Publicado: (2014)

The polarity protein Angiomotin p130 controls dendritic spine maturation
por: Wigerius, Michael, et al.
Publicado: (2018)

Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer
por: Yang, Jing, et al.
Publicado: (2022)

Double agents: genes with both oncogenic and tumor-suppressor functions
por: Shen, Libing, et al.
Publicado: (2018)

Angiomotin: An Angiostatin Binding Protein That Regulates Endothelial Cell Migration and Tube Formation
por: Troyanovsky, Boris, et al.
Publicado: (2001)

Angiomotin links ROCK and YAP signaling in mechanosensitive differentiation of neural stem cells
por: Kang, Phillip H., et al.
Publicado: (2020)

Somatic selection distinguishes oncogenes and tumor suppressor genes
por: Chandrashekar, Pramod, et al.
Publicado: (2019)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors
por: Arigoni, Maddalena, et al.
Publicado: (2012)

Cadherin Related Family Member 2 Acts As A Tumor Suppressor By Inactivating AKT In Human Hepatocellular Carcinoma
por: Xia, Ziyuan, et al.
Publicado: (2019)

Angiomotin Regulates YAP Localization during Neural Differentiation of Human Pluripotent Stem Cells
por: Zaltsman, Yefim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q21i4djsijk4qpsco818umdbnq